betahistine has been researched along with Weight Gain in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH | 1 |
| Kotańska, M; Mika, K; Sapa, J; Szafarz, M | 1 |
| Ali, AA; El-Din, ASGS; El-Menshawe, SF; Elkomy, MH; Halawa, AA | 1 |
| Ali, AA; El-Menshawe, SF; Halawa, AA; Srag El-Din, AS | 1 |
| Davis, JM; Jin, H; Jing, Z; Maayan, L; Meyers, J; Sershen, H; Smith, RC; Szabo, V; Wu, R; Youssef, M; Zhao, J | 1 |
| Amalanathan, S; Augustine, AM; Balraj, A; Lepcha, A; Tyagi, AK | 1 |
| Deng, C; Huang, XF; Lian, J; Pai, N | 4 |
| Deng, C; Hu, CH; Lian, J; Liu, X | 1 |
| Albeck, JH; Barak, N; Beck, Y | 2 |
| Reynolds, GP | 1 |
| Fuchs, C; Levi, A; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
| Levi, A; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
2 review(s) available for betahistine and Weight Gain
| Article | Year |
|---|---|
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Nizatidine; Ranitidine; Reboxetine; Schizophrenia; Topiramate; Weight Gain | 2022 |
Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Benzodiazepines; Betahistine; Histamine Agonists; Humans; Olanzapine; Receptors, Histamine H1; Weight Gain | 2016 |
6 trial(s) available for betahistine and Weight Gain
| Article | Year |
|---|---|
Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Betahistine; Body Mass Index; Body Weight; Child; Clozapine; Double-Blind Method; Female; Histamine Agonists; Humans; Male; Olanzapine; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult | 2018 |
Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.
Topics: Acetaminophen; Adolescent; Adult; Aged; Betahistine; Calcium Channel Blockers; Disorders of Excessive Somnolence; Drug Therapy, Combination; Female; Flunarizine; Histamine Agonists; Histamine Antagonists; Humans; Male; Middle Aged; Migraine Disorders; Vertigo; Weight Gain; Young Adult | 2014 |
Betahistine decreases olanzapine-induced weight gain and somnolence in humans.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Brain; Double-Blind Method; Female; Histamine Agonists; Humans; Olanzapine; Receptors, Histamine H1; Sleep Initiation and Maintenance Disorders; Weight Gain | 2016 |
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Betahistine to Counteract Olanzapine-Associated Weight Gain.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Double-Blind Method; Drug Therapy, Combination; Female; Histamine Agonists; Humans; Internationality; Male; Olanzapine; Pilot Projects; Psychotic Disorders; Schizophrenia; Weight Gain; Young Adult | 2016 |
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Double-Blind Method; Female; Histamine Agonists; Humans; Male; Middle Aged; Morpholines; Olanzapine; Reboxetine; Schizophrenia; Treatment Outcome; Weight Gain; Young Adult | 2013 |
The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Betahistine; Body Mass Index; Body Weight; Histamine Agonists; Histamine Antagonists; Humans; Olanzapine; Receptors, Histamine H3; Schizophrenia; Weight Gain | 2005 |
8 other study(ies) available for betahistine and Weight Gain
| Article | Year |
|---|---|
Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats.
Topics: Animals; Anti-Obesity Agents; Betahistine; Diet; Dietary Fats; Female; Histamine Agonists; Hormones; Hyperphagia; Metabolism; Motor Activity; Rats; Rats, Wistar; Sugars; Weight Gain | 2021 |
Betahistine dihydrochloride transdermal delivery via optimized thermosensitive gels: percutaneous absorption evaluation using rat growth as a biomarker.
Topics: Administration, Cutaneous; Animals; Betahistine; Biomarkers; Delayed-Action Preparations; Eating; Female; Gels; Histamine Agonists; Polymers; Rats; Skin; Skin Absorption; Temperature; Viscosity; Weight Gain | 2018 |
A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization.
Topics: Adipose Tissue; Administration, Oral; Animals; Betahistine; Eating; Female; Gels; Inflammation; Nanostructures; Particle Size; Rats; Surface Properties; Weight Gain | 2017 |
Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
Topics: Adenylate Kinase; Adiposity; Animals; Antipsychotic Agents; Benzodiazepines; Betahistine; Eating; Female; Histamine; Histamine Agonists; Neuropeptide Y; Olanzapine; Rats; Rats, Sprague-Dawley; Signal Transduction; Weight Gain | 2014 |
Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.
Topics: Adipose Tissue, Brown; Adiposity; Animals; Benzodiazepines; Betahistine; Disease Models, Animal; Feeding Behavior; Female; Hypothalamus; Lipid Droplets; Liver; Olanzapine; Organ Size; Rats, Sprague-Dawley; Weight Gain | 2014 |
Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Benzodiazepines; Betahistine; Dyslipidemias; Female; Liver; Olanzapine; PPAR alpha; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Sterol Regulatory Element Binding Protein 1; Weight Gain | 2015 |
Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
Topics: Animals; Antipsychotic Agents; Appetite Depressants; Behavior, Animal; Benzodiazepines; Betahistine; Disease Models, Animal; Drug Interactions; Exploratory Behavior; Feeding Behavior; Female; Histamine Agonists; Histamine H3 Antagonists; Hyperphagia; Motor Activity; Olanzapine; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Weight Gain | 2012 |
Histamine and antipsychotic drug-induced weight gain.
Topics: Animals; Antipsychotic Agents; Appetite Depressants; Benzodiazepines; Betahistine; Disease Models, Animal; Female; Hyperphagia; Weight Gain | 2012 |